Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Landi, MT"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 84
Tytuł:
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)
Autorzy:
Harland M (AUTHOR)
Goldstein AM (AUTHOR)
Kukalizch K (AUTHOR)
Taylor C (AUTHOR)
Hogg D (AUTHOR)
Puig S (AUTHOR)
Badenas C (AUTHOR)
Gruis N (AUTHOR)
ter Huurne J (AUTHOR)
Bergman W (AUTHOR)
Hayward NK (AUTHOR)
Stark M (AUTHOR)
Tsao H (AUTHOR)
Tucker MA (AUTHOR)
Landi MT (AUTHOR)
Scarra GB (AUTHOR)
Ghiorzo P (AUTHOR)
Kanetsky PA (AUTHOR)
Elder D (AUTHOR)
Mann GJ (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. Jun2008, Vol. 44 Issue 9, p1269-1274. 6p.
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification.
Autorzy:
Wang X; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, 667 Huntington Ave, Boston, MA, 02115, USA.
Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ding Y; Bioinformatics Interdepartmental Program, University of California, Los Angeles, USA.
Chen T; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Mucci L; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Lam S; Department of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada.
Tardon A; Faculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.
Chen C; Department of Epidemiology, University of Washington School of Public Health, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Bojesen SE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Johansson M; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Risch A; Department of Biosciences and Medical Biology, Allergy-Cancer-BioNano Research Centre, University of Salzburg, and Cancer Cluster Salzburg, Salzburg, Austria.
Bickeböller H; Department of Genetic Epidemiology, University Medical Center, Georg August University Göttingen, Göttingen, Germany.
Wichmann HE; Institute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany.
Rennert G; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Carmel, Haifa, Israel.
Arnold S; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Brennan P; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
McKay JD; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Field JK; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Shete SS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Liu G; Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Andrew AS; Department of Epidemiology, Department of Community and Family Medicine, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Kiemeney LA; Department for Health Evidence, Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Zienolddiny-Narui S; National Institute of Occupational Health, Oslo, Norway.
Behndig A; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Johansson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
Cox A; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK.
Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, WA, USA.
Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Aldrich MC; Department of Medicine, Department of Biomedical Informatics and Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Hung RJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Amos CI; Institute for Clinical and Translational Research, Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Lin X; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Christiani DC; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, 667 Huntington Ave, Boston, MA, 02115, USA. .; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Feb 05; Vol. 16 (1), pp. 22. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Genetic Risk Score*
Lung Neoplasms*/genetics
Humans ; Bayes Theorem ; Genome-Wide Association Study ; Uncertainty ; Risk Assessment ; Risk Factors ; Genetic Predisposition to Disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic variants for smoking behaviour and risk of skin cancer.
Autorzy:
Dusingize JC; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Law MH; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Seviiri M; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Olsen CM; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Pandeya N; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Iles MM; Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Neale RE; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Ong JS; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
MacGregor S; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Whiteman DC; Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. .; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 06; Vol. 13 (1), pp. 16873. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Skin Neoplasms*/etiology
Skin Neoplasms*/genetics
Carcinoma, Squamous Cell*/pathology
Carcinoma, Basal Cell*/etiology
Carcinoma, Basal Cell*/genetics
Melanoma*/etiology
Melanoma*/genetics
Humans ; Smoking/adverse effects ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Risk Factors ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting.
Autorzy:
Seviiri M; Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD, 4006, Australia. .; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia. .; Center for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia. .
Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia.
Bishop DT; Division of Haematology and Immunology, Leeds Institute of Medical Research at St James', University of Leeds, Leeds, UK.
Newton-Bishop JA; Division of Haematology and Immunology, Leeds Institute of Medical Research at St James', University of Leeds, Leeds, UK.
Iles MM; St James's Institute of Medical Research, University of Leeds, Leeds, UK.; Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Sydney Head & Neck Cancer Institute, Chris O'Brien Lifehouse Cancer Center, Sydney, NSW, Australia.
Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Breast and Melanoma Surgery, Royal North Shore Hospital, Sydney, NSW, Australia.
Gordon SD; Genetic Epidemiology Lab, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Olsen CM; Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Whiteman DC; Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Medical Oncology, Mater Hospital, North Sydney, NSW, Australia.; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia.
MacGregor S; Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD, 4006, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Law MH; Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD, 4006, Australia. .; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Sep 05; Vol. 20 (1), pp. 403. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/genetics
Skin Neoplasms*/genetics
Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Polymorphism, Single Nucleotide/genetics ; Ultraviolet Rays ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SUITOR: Selecting the number of mutational signatures through cross-validation.
Autorzy:
Lee D; Department of Statistics, Pusan National University, Busan, Korea.
Wang D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Shi J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Zhu B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2022 Apr 04; Vol. 18 (4), pp. e1009309. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Breast Neoplasms*/genetics
Neoplasms*
Computer Simulation ; Female ; Genomics ; Humans ; Mutation/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors.
Autorzy:
Hoang PH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Feb 15; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 15.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 84

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies